Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-02-25 @ 8:50 PM
Study NCT ID:
NCT03799003
Status:
TERMINATED
Last Update Posted:
2024-11-01
First Post:
2019-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ASP1951 in Subjects With Advanced Solid Tumors
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ASP1951 | View |
| None | cervical cancer | View |
| None | Oncology | View |
| None | squamous cell carcinoma of the head and neck (SCCHN) | View |
| None | metastatic castration-resistant prostate cancer (mCRPC) | View |
| None | melanoma | View |
| None | Tumors | View |
| None | pembrolizumab | View |
| None | colorectal cancer | View |
| None | Advanced (unresectable) or metastatic solid tumor malignancies | View |
| None | Advanced solid tumors | View |